# Hiroyasu Higuchi

- Location (FDA's records): Tokyo, JP
- FDA decisions: 1 (2012–2012): 1 510(k) clearance
- Product codes: OKS (1)
- Predicates its devices cite: 2 (0 its own); citations of its devices by later devices: 2 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Fci Ophthalmics, Inc.: 2 (https://510kreport.com/company/fci-ophthalmics)

## Firms that cite its devices most
- Fci (France Chirurgie Instrumentation) Sas: 1 (https://510kreport.com/company/fci-france-chirurgie-instrumentation)
- Kaneka Pharma America, LLC: 1 (https://510kreport.com/company/kaneka-pharma-america)

## Its most-cited devices
- K120886: Lacrifast (2012), cited by 2

## Recent decisions
- K120886: Lacrifast (Dec 17, 2012)

Source page: https://510kreport.com/company/hiroyasu-higuchi